A critical review of mRNA vaccine safety and efficacy from mechanistic and public health perspectives
By
Anna K Blakney, PhDa Send email to [email protected]
Summary
This article provides a critical review of mRNA vaccine safety and efficacy from mechanistic, preclinical, clinical, and public health perspectives. It highlights mRNA vaccines as a transformative advance in vaccinology with rapid development timelines, scalable manufacturing, and strong immunogenicity. The review draws on the unprecedented real-world evaluation from billions of COVID-19 vaccine doses administered globally across diverse populations.
Source
Twitter / XA critical review of mRNA vaccine safety and efficacy from mechanistic and public health perspectivesthelancet.comKey quotes
· 3 pulledmRNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing, and strong immunogenicity with a favourable safety profile.
Global deployment of mRNA vaccines during the COVID-19 pandemic provided an unprecedented real-world evaluation of this platform, with billions of doses administered across diverse populations.
In this Review, we critically examine the safety and efficacy of mRNA vaccines from mechanistic, preclinical, clinical, and public health perspectives.
You might also wanna read
Lancet Review Confirms mRNA COVID-19 Vaccines Are Safe, Effective, and Paving the Way for Cancer Treatments
A new review published in The Lancet, led by researchers at the University of British Columbia, examines the body of evidence on mRNA COVID-
discovermagazine.com·2d ago
Moderna's combined flu and COVID-19 mRNA vaccine shows durable immune response in mid-stage trial
Moderna announced promising results from a mid-stage trial of its combined mRNA seasonal flu and COVID-19 vaccine (mRNA-1073). The study inv
cidrap.umn.edu·21d ago
HHS Ends mRNA Vaccine Development Under BARDA Following Review
The U.S. Department of Health and Human Services (HHS) has announced the wind-down of its mRNA vaccine development activities under BARDA, i
hhs.gov·11mo ago
Personalized mRNA vaccine shows promise in preventing melanoma recurrence when combined with immunotherapy
An 80-year-old melanoma patient, Connie Franciosi, participated in a clinical trial testing an mRNA cancer vaccine (mRNA-4157/V940) combined
share.google·1mo ago
Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59
This cohort study analyzes data from over 28 million French adults aged 18-59 to examine the association between mRNA COVID-19 vaccination a
jamanetwork.com·7mo ago
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·8d agoWhy COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
clinicaltrialsabundance.blog·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.